Related by context. All words. (Click for frequent words.) 68 immuno inflammatory diseases 67 cardiovascular metabolic 67 inflammatory diseases 67 Functional Somatic Syndromes 66 inflammatory disorders 66 neuropathic pain 66 cardiovascular disorders 65 ophthalmic diseases 64 therapeutics 64 Fibromyalgia Syndrome FMS 63 CNS gastrointestinal GI 63 dermatological diseases 63 tiapamil 62 metabolic diseases 62 neurodegenerative diseases 62 fibrotic diseases 62 metabolic disorders 61 immunological diseases 61 renal diseases 61 neurological diseases 61 ocular diseases 61 Ischemic Spastic Paraplegia Traumatic 60 autoimmune diseases 60 inflammatory autoimmune 60 psoriasis rheumatoid arthritis 60 Systemic RNAi TM 60 anti infectives cardiovascular 60 gastrointestinal disorders 60 investigational therapies 59 Multiple sclerosis MS 59 autoimmune diseases inflammation 59 cognitive impairment associated 59 ALN PCS 59 rheumatoid arthritis multiple sclerosis 59 neurodegenerative disorders 58 cardio renal 58 CNS hematology oncology 58 injury ischemic spastic 58 commercializing therapeutic 58 degenerative disorders 58 lipid disorders 58 neuro inflammatory 58 small molecule therapeutics 58 Friedreich Ataxia FRDA 58 CNS therapeutics 58 cardiovascular gastrointestinal 58 autoimmune disorders 58 novel antibody therapeutics 58 NNR Therapeutics 58 NovaBay Aganocide compounds 58 retinal disorders 57 Alzheimer disease epilepsy 57 fibromyalgia syndrome 57 multiple sclerosis rheumatoid arthritis 57 immunologic diseases 57 quinidine sulfate 57 psoriasis psoriatic arthritis 57 NNRs 57 autoimmune 57 RNAi therapeutic 57 novel therapeutics 57 histone methyltransferases HMTs 57 thrombotic diseases 57 diabetic nephropathy 57 neuronal nicotinic receptors NNRs 57 disorders infectious diseases 57 GI motility disorders 57 monoclonal antibody therapeutics 57 Nanobody 57 autoimmune uveitis 57 rheumatoid arthritis psoriasis 56 NTDDS 56 demyelinating disorders 56 hematologic diseases 56 epilepsy Parkinson disease 56 small molecule 56 CCR9 antagonist 56 respiratory gastrointestinal 56 Neurodegenerative diseases 56 autoimmune diseases inflammatory 56 therapeutic modalities 56 neurological disorders 56 TTR amyloidosis 56 musculoskeletal diseases 56 therapies 56 kidney urologic 56 diagnostic molecular imaging 56 transthyretin TTR mediated amyloidosis 56 subsidiaries Laboratorios Belmac Laboratorios 56 ALN TTR 56 non alcoholic steatohepatitis 56 BEMA Buprenorphine 56 anti infective 56 thetreatment 56 neuropathic pain metabolic diseases 56 skeletal muscle contractility 56 chronic inflammatory 56 ALN HTT 56 dermatological disorders 56 venomics 56 Inc. Nasdaq NLTX 55 Revimmune TM 55 disorders 55 PDE# inhibitors 55 osteoarthritis rheumatoid arthritis 55 skeletal muscle weakness 55 therapeutic monoclonal antibodies 55 investigational compounds 55 hypertension osteoarthritis 55 interventional therapies 55 romazarit 55 vascular diseases 55 NYSE Amex AEN 55 nociceptive pain 55 rheumatic diseases 55 diarrhea predominant irritable 55 Systemic lupus erythematosus SLE 55 either acutely decompensated 55 CB1 antagonists 55 immunotherapeutics 55 Disease IBD 55 POSIDUR TM ELADUR TM 55 Pimavanserin 55 familial amyloidotic polyneuropathy FAP 55 REMOXY ® 55 neurovascular diseases 55 GPCR targets 55 Chrysalin 55 infectious diseases autoimmune 55 p# inhibitor 55 Central Nervous System 55 selective androgen receptor modulators 55 Parkinson disease epilepsy 55 Nanobody ® 55 immunological disorders 55 migraines neurorehabilitation 55 proliferative diseases 55 Delta opioid receptor 55 Solazed TM 55 constipation OIC 55 SARMs 55 RNAi therapeutic targeting 55 P#X# antagonist 55 oncology therapeutics 55 neuropsychiatric diseases 55 antibody therapeutics 55 endocrine diseases 55 antisense drugs 55 protein therapeutics 55 CNS hemorrhage 55 cardiac muscle contractility 55 gastrointestinal disorders ATI 55 diagnostic biomarkers 55 systemic fungal infections 55 Tasimelteon 55 molecular imaging radiopharmaceutical 54 nicotinic alpha 7 54 PsychoGenics 54 acetonide FA 54 pain syndromes 54 inflammatory demyelinating 54 targeted radiotherapeutics 54 Alzheimer disease cognitive impairment 54 Pyridorin 54 identify protein biomarkers 54 Serdaxin 54 diabetic neuropathic pain 54 neuro degenerative diseases 54 anti infective treatments 54 oncology 54 sodium thiosulfate STS 54 Ampakine compounds 54 peripherally acting 54 Adnectin 54 polyneuropathy HIV DSP 54 Cerimon 54 REMOXY R 54 neurodegenerative disease 54 ophthalmology oncology 54 Archexin 54 pulmonary arterial hypertension PAH 54 J. Donald deBethizy 54 novel anti infective 54 Factor VIIa 54 cancer therapeutics 54 Dual Opioid TM 54 degenerative diseases 54 autoimmune inflammatory 54 liver cancers hypercholesterolemia 54 insomnia migraine headaches 54 neuropsychiatric disorders 54 gastrointestinal disorders characterized 54 debilitating autoimmune 54 retinal diseases 54 preclinical compounds 54 Ceflatonin R 54 Stapled Peptide 54 adenosine A2A 54 Milnacipran 54 myeloproliferative disorders 54 lupus nephritis 54 rheumatoid arthritis thrombocytopenia 54 myelofibrosis polycythemia vera 54 DDP# 54 oncology indications 54 rheumatoid arthritis Crohn disease 54 IAP inhibitors 54 microRNA therapeutics 54 Ph.D. Targacept 54 glucokinase activator 54 siRNA therapeutics 54 Promedior 54 flupirtine 54 rxRNA 54 neuropathic pain spasticity 54 cardiometabolic 54 prokinetic agent 54 rheumatoid arthritis psoriasis Crohn 54 RNAi therapeutics 53 cardiometabolic disorders 53 Combivir Kivexa 53 chronic neuropathic pain 53 biologic therapies 53 epigenetic enzymes 53 JAK2 inhibitor 53 Frozen Shoulder Syndrome 53 TMS Therapy 53 refractory gout 53 fibrosis oncology 53 targeting PCSK9 53 Zemiva TM 53 rheumatoid arthritis psoriatic arthritis 53 OXIGON TM 53 Neuraltus 53 refractory angina 53 symptomatic neurogenic orthostatic hypotension 53 renin inhibitors 53 urological disorders 53 Parkinson disease multiple sclerosis 53 novel peptide 53 opioid induced constipation 53 cardiovascular diseases 53 Aviptadil 53 ophthalmic indications 53 leukotriene pathway 53 Alzheimer disease frontotemporal dementia 53 SYN# 53 neuro inflammatory disorders 53 fibrotic disease 53 personalized cellular immunotherapy 53 Arcalyst 53 pharmacotherapies 53 purinergic receptors P#X# 53 hypoparathyroidism 53 Logical Therapeutics 53 lupus multiple sclerosis 53 MEK inhibitor 53 Supernus Pharmaceuticals 53 PDE# 53 LUNESTA ® 53 antithrombotics 53 neurogenic 53 disease modifying 53 Homspera TM 53 CB2 selective 53 myasthenia gravis Huntington 53 Mipomersen 53 Nerve Targeting Drug 53 Cetrorelix 53 JAK inhibitor 53 oncology cardiology 53 Zingo TM 53 vascular disorders 53 Addrenex 53 ACV1 53 THR beta agonist 53 Liprotamase 53 Campath ® 53 rheumatoid arthritis 53 investigational humanized monoclonal antibody 53 Rheumatoid Arthritis RA 53 hematological diseases 53 autologous cellular therapies 53 Asthma COPD 53 G Protein Coupled 53 rheumatologic 53 urologic disease 53 Receptors GPCRs 53 anticancer therapeutics 53 postoperative ileus 53 acne impetigo 53 polyneuropathy CIDP 53 Repligen Corporation 53 neuronal nicotinic receptors 53 TOPIGEN 53 post herpetic neuralgia PHN 53 photodisinfection 53 NASDAQ SNTA biopharmaceutical 53 chemical entities NCEs 53 topically delivered 53 OTCBB NRGX biotechnology 53 hereditary angioedema 53 anti infectives 53 vaccines oncolytic virus 53 BCR ABL inhibitors 52 inflammatory autoimmune diseases 52 Regado 52 rheumatoid arthritis juvenile idiopathic 52 commercializing anti infective 52 asthma COPD Chronic 52 antisense therapeutics 52 macular degeneration diabetic retinopathy 52 voiding dysfunctions 52 dermatology therapies 52 oncolytic virus therapies 52 CNS depressants 52 myelination disorders 52 gastroenterology neurology 52 NP2 Enkephalin 52 Genasense evaluating 52 SGLT inhibitors 52 degenerative neurological diseases 52 hematologic disorders 52 HQK 52 proteasome inhibitors 52 neurotology neuropsychology headaches 52 Lupuzor 52 StromaCel Inc. 52 GGF2 52 Oracea TM 52 protein misfolding diseases 52 Ketotransdel TM 52 anticancer therapies 52 BHT DNA 52 AMPK activators 52 MTP inhibitor 52 viral diseases 52 BioMarin develops 52 siRNA compounds 52 ProSavin 52 commercializing novel 52 erythematosus 52 Soliris eculizumab 52 benign prostatic hypertrophy BPH 52 neuromodulation therapies 52 chronic myocardial ischemia 52 Cogane 52 molecular biomarkers 52 Panzem R 52 infectious diseases autoimmune diseases 52 gastrointestinal GI disorders 52 Fabry Disease 52 dexanabinol 52 Bicifadine 52 oncology metabolic disorders 52 norepinephrine reuptake inhibitor 52 QUADRAMET R 52 fibrotic disorders 52 HIV associated lipodystrophy 52 targeted radiotherapeutic 52 prostone 52 vitreoretinal disorders 52 Autoimmune disorders 52 antiangiogenesis therapies 52 DOS# 52 REG1 52 oncology endocrinology 52 neuropathies 52 anemias 52 tranilast 52 Autoimmune diseases 52 Aegera 52 vidofludimus 52 Applied NeuroSolutions 52 AMPAKINE compounds 52 therapeutic 52 peptide peptide mimetic 52 PORxin TM platforms 52 cannabinor 52 neovascular diseases 52 NASDAQ DYAX 52 neuropathic 52 including eniluracil ADH 52 topical dermatology 52 PLX cells 52 PDE7 52 Synavive ™ 52 receptor tyrosine kinase inhibitor 52 anti amnesic 52 opioid induced 52 PLX MS 52 opioid bowel dysfunction 52 chronic neuropathic 52 ELADUR ™ 52 Chemokine Therapeutics 52 anticancer compounds 52 URG# 52 P#X# 52 Major Depressive Disorder MDD 52 Onalta 52 AutoloGel tm System 52 ATL# [002] 52 chemotherapy induced neutropenia 52 JAK1 52 KineMed 52 pharmacologic agents 52 Inc. Nasdaq ALNY 52 RhuDex ® 52 osteolytic bone disease 52 Sudhir Agrawal D.Phil 52 therapeutic antibodies 52 small molecule activator 52 IL# PE#QQR 52 novel immunotherapies 52 Microplasmin 52 cachexia 52 psychiatric disorders 52 anticoagulant reversing agent 52 protein kinase inhibitors 52 Alzheimer Disease AD 52 Ankylosing Spondylitis AS 52 neurodegenerative 52 antibody therapies 52 Lu AA# 52 neuromuscular spasm 52 Symadex 51 MEK inhibitors 51 rxRNA compounds 51 molecular imaging radiopharmaceuticals 51 XmAb ® 51 HeFH 51 Phylomer ® 51 Exelixis compounds 51 Uli Hacksell Ph.D. 51 isoform selective 51 immune mediated 51 Irritable Bowel Syndrome IBS 51 ophthalmology dermatology cardiovascular disease 51 HP Acthar Gel repository 51 commercializes innovative biopharmaceuticals 51 NASDAQ ALTH biopharmaceutical 51 Nasdaq IDRA 51 pseudobulbar affect PBA 51 OTCBB HPLF FWB HL1 51 Unit Dose Budesonide 51 biologic therapeutics 51 gastrointestinal diseases 51 CYT# potent vascular disrupting 51 Cushing Syndrome 51 neurogenic orthostatic hypotension 51 allosteric modulation 51 pharmacological chaperone 51 melanocortin receptors 51 GlycoPEGylated hemostasis compounds 51 Ception Therapeutics 51 Entereg R 51 TRAIL receptor antibodies 51 sJIA 51 cardio cerebral vascular 51 FOLOTYN ® 51 Vipin K. 51 NYSE Amex RNN 51 OTCBB NVLT biopharmaceutical 51 immuno inflammatory 51 tezampanel 51 hereditary emphysema 51 stem cell therapeutics 51 Immunotherapeutic 51 MEK inhibitor RDEA# 51 diseases fat malabsorption 51 selective immunoproteasome inhibitor 51 Omeros Corporation 51 CD# CEA 51 samarium Sm 51 respiratory disorders 51 ophthalmic therapeutics 51 NeurAxon Inc. 51 selective inhibition 51 Prodarsan ® 51 equine osteoarthritis 51 oncology immunology 51 immunoregulation 51 Parkinson disease Alzheimer disease 51 Nasdaq HALO biopharmaceutical 51 proprietary dermal 51 Pervasis 51 demyelinating disease 51 Icatibant 51 oncological indications 51 delivered RNAi therapeutic 51 Zenvia ™ 51 oxypurinol 51 TRV# [001] 51 Davunetide 51 hematologic malignancies 51 treat gastrointestinal disorders 51 opioid receptor antagonist 51 Nektar PEGylation technology 51 sirtuin therapeutics 51 delay bone metastases 51 DepoDur 51 Squalamine 51 epilepsy multiple sclerosis 51 neuro vascular 51 DETERx ™ 51 mGluR4 PAM 51 target Galectin receptors 51 Prodarsan R 51 biased ligand 51 patented Bioral R nanocochleate 51 QuatRx 51 agomelatine 51 receptor agonists 51 carcinoid syndrome 51 adrenergic regulation 51 tubulin inhibitor 51 HCV protease inhibitors 51 infectious autoimmune 51 Onalta TM 51 Savella ® 51 treating cancerous tumors 51 Neuropathic pain 51 cMET 51 angioedema indications 51 constipation IBS C 51 diabetic neuropathy 51 selective inhibitors 51 branch RVO 51 Serdolect ® 51 inflammatory bowel disease 51 markets Gelclair R 51 enhance ApoA 51 Andara OFS 51 Syndrome RLS 51 HepDirect 51 systemic RNA interference 51 severe malignant osteopetrosis 51 RNA antagonists 51 Nasdaq OMER 51 crofelemer 51 Gemin X 51 liver cancers TTR 51 Azedra TM 51 Friedreich Ataxia 51 peptide therapeutics 51 derivatives Radilex TM 51 INxin TM 51 renin angiotensin aldosterone 51 unmet medical 51 Pazopanib 51 oncologic diseases 51 Adenosine Therapeutics 51 muscarinic receptor agonist 51 organ transplant rejection 51 investigational monoclonal antibody 51 multitargeted 51 Genentech Rituxan 51 Vaccinex 51 immunomodulators 51 cardiac arrhythmias 51 Cryopyrin Associated Periodic Syndromes 51 Valdoxan 51 postherpetic neuralgia PHN painful 51 siRNA delivery 51 Flutiform TM 51 ophthalmologic disorders 51 GW# [003] 51 investigational drug 51 diabetic peripheral neuropathy 51 Actemra tocilizumab 51 glucagon receptor 51 hematological malignancies 51 Elagolix 51 LentiVector technology 51 tizanidine hydrochloride short 51 HepDirect R 51 Kleanthis G. Xanthopoulos Ph.D. 51 oligonucleotide therapeutics 51 synthetic retinoid 51 myelofibrosis 51 topical anti infective 51 renin inhibition promising 51 Enkephalin 51 Provectus Pharmaceuticals specializes 51 ospemifene 51 mu opioid receptor antagonist 51 antibody therapeutics targeting 51 lomitapide 51 RNA antagonist 51 essential thrombocythemia 51 demyelinating diseases 51 excessive underarm sweating 51 DiaKine 51 neuroprotection 51 MAXY VII 51 Selzentry Celsentri 51 Locked Nucleic Acid LNA 51 Tyrima 51 ATG Fresenius S 51 histone deacetylase HDAC inhibitor 51 Zipsor 50 Daclizumab 50 Tranzyme 50 Tovaxin ® 50 small molecule inhibitors 50 gastrointestinal mucositis 50 commercialize pimavanserin 50 Hereditary angioedema HAE 50 resistant bacterial infections 50 Spiro Rombotis President 50 inflammatory bowel diseases 50 TARIS 50 Xyfid TM 50 multiple sclerosis degenerative 50 5 HT6 receptor 50 PDE4 inhibitors 50 proteasome inhibitor 50 GED aPC 50 rheumatoid 50 HIV distal sensory 50 post herpetic neuralgia 50 NuMimetic TM 50 5 HT2A receptor 50 inflammatory cardio metabolic 50 cancer immunotherapies 50 SMT C# 50 inflammatory arthritis 50 Mersana 50 Acute Lung 50 recombinant therapies 50 therapeutic antibody 50 hormone gastrin 50 therapeutic modality 50 Cinquil 50 relapsed leukemia 50 hematological disorders 50 OMNARIS HFA 50 topical NSAID 50 Synergy Pharmaceuticals 50 epilepsies 50 PDE4 inhibitor 50 ILUVIEN ® 50 dermatologic conditions 50 regenerative therapies 50 AMPAKINE 50 regorafenib 50 Inflammatory Bowel Disease 50 chronic renal disease 50 candidate voreloxin 50 treating neuropathic pain 50 IMiDs 50 PDE inhibitors 50 Guanilib 50 Serostim ® 50 investigating Serdaxin 50 epothilones 50 ibudilast 50 Ikaria Holdings Inc. 50 Triolex 50 Nanobodies R 50 Personalized Immunotherapy 50 MPS IVA 50 NYSE Amex PTN 50 mGluR2 NAM 50 RNA interference RNAi therapeutics 50 antiviral therapeutics 50 atherosclerosis hypertension 50 medically refractory 50 transdermal delivery 50 inherited retinal 50 Myelofibrosis 50 gastrointestinal GI 50 Factor VIIa Factor VIII 50 muscular dystrophies 50 XIAFLEX ® 50 NASDAQ BTRX pharmaceutical 50 novel peptide therapeutics 50 Tranzyme Pharma 50 engineered RAP peptides 50 novel antiviral therapeutics 50 coagulation disorders 50 zanolimumab 50 Viprovex TM 50 myeloproliferative neoplasms 50 neuromodulation 50 Hedgehog pathway 50 Lixivaptan 50 BXT # 50 JAK3 50 ZEVALIN ® 50 CTLA4 Ig product 50 Savella TM 50 targeted immunotherapies 50 gastro intestinal disorders 50 Atiprimod 50 candidate deforolimus 50 overactive bladder syndrome 50 beta secretase inhibitors 50 investigational hepatitis C 50 arterial thrombosis 50 Oramed 50 refractory epilepsy 50 cardio metabolic diseases 50 CRMD pharmaceutical 50 mGluR2 50 neuroprotective properties 50 EHT AGN 50 Archemix Corp. 50 Acologix 50 Cx# [002] 50 CTAP# Capsules 50 human antibody therapeutics 50 Crohn disease CD 50 HepDirect technology 50 CEQ# 50 mixed dyslipidemia 50 chronic viral infections 50 terlipressin 50 novel immunomodulatory 50 Parnate 50 bipolar disorder schizophrenia 50 Cylene 50 commercializing novel biotherapeutics 50 pan HDAC inhibitor 50 LHRH antagonists 50 regenerative therapeutics 50 SYGNIS 50 heterozygous FH 50 IMiDs R 50 Obstructive Pulmonary Disease 50 Xanafide 50 TLR Therapeutics 50 diseases NTDs 50 lymphoma leukemia 50 immunotherapies 50 GRN# 50 disorder OCD 50 Nanobodies 50 nebulized budesonide 50 AMPAKINE R 50 Nasdaq RXII 50 PNP inhibitor 50 Brussels THR 50 Nasdaq VRTX 50 PDE4 modulators 50 retinal degenerative diseases 50 nitric oxide donating 50 KL4 Surfactant 50 candidates Azedra TM 50 CB2 selective receptor agonist 50 INCB# [003] 50 neuroendocrine cancers 50 NASDAQ CYTR biopharmaceutical 50 Safinamide 50 Iluvien ® 50 NASDAQ CORT 50 mGluR2 positive 50 cardiovascular metabolic diseases 50 antibacterial therapeutics 50 antagomirs 50 allosteric modulator PAM 50 Pirfenidone 50 aptamer therapeutics 50 COMT inhibitors 50 mGluR5 PAM 50 allosteric modulator 50 commercialize elagolix 50 KuDOS 50 relapsing forms 50 CTLA4 Ig 50 mGluR4 mGluR2 mGluR5 50 gastrointestinal GI motility disorders 50 ALN TTR# 50 vascular disrupting agents 50 injectable formulation 50 antisense inhibitors 50 fatty acid amide hydrolase 50 GERD migraine headaches 50 ANTISENILIN ® 50 cardiovascular anti infectives 50 peptibody 50 oral Janus kinase 50 Rotigotine 50 Chronic Inflammatory Demyelinating Polyneuropathy 50 RECOTHROM ® 50 liposomal delivery 50 herpetic keratitis 50 lysosomal storage disorders 50 orally inhaled migraine 50 Interferon beta 50 histone deacetylase 50 sodium glucose transporter 50 HCV polymerase inhibitors 50 phase IIa clinical 50 systemic lupus erythematosus lupus 50 generation proteasome inhibitor 50 bioactive lipids 50 CHDI Foundation 50 partial agonist 50 Inc. NASDAQ AEZS 50 tafamidis 50 OX1 50 Salmedix 50 Nanobody R 50 acute decompensated heart 50 3 kinase PI3K 50 Diasome 50 VEGF receptor 50 Hsp# inhibition 50 systemic lupus erythematosus 50 metabotropic glutamate receptors 50 peripheral vascular disease 50 mGluR4 50 MCSP respectively 50 IAP inhibitor 50 Nasdaq PARD biopharmaceutical 50 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 50 AKIP ™ 50 ALD# 50 OTCBB PYTO 50 Dr. Aiping Young 50 acute migraine 50 preclinical 50 angiogenic responses 50 Targeted Chemotherapy 50 chronic degenerative diseases 50 CB2 receptor 50 clinically validated targets 50 osteoarthritic pain 50 immunology oncology 50 systemic juvenile idiopathic 50 NexACT ® technology 50 Rebif ® 50 peripheral neuropathies 50 autoimmune disease 50 Nasdaq OMER biopharmaceutical 50 efficacious treatments 50 Inc. NASDAQ NLTX 50 ZARS Pharma 50 AMEX RGN 50 ALTROPANE 50 HuCNS SC ® 50 imaging radiopharmaceuticals 50 dyslipidemia hypertension diabetes 50 psoriasis Crohn disease 50 molecular radiotherapeutics 50 opioid induced bowel dysfunction 50 oncology neuroscience 49 AA amyloidosis 49 Intellikine 49 Alzheimer disease Parkinson disease 49 Mucositis 49 DNAi 49 Nanobodies ® 49 TÎ ² 4 49 postoperative ileus POI 49 cognitive disorders 49 elotuzumab 49 Injury ALI 49 protein tyrosine phosphatases 49 multi kinase inhibitor 49 YONDELIS 49 immunotherapeutic 49 small molecule modulators 49 systemic autoimmune 49 primary Restless Legs 49 Pregabalin 49 Ophthotech 49 immune modulation 49 Parkinson Disease PD 49 GABITRIL 49 dyslipidemias 49 severe gastroparesis 49 reuptake inhibitors 49 PAOD 49 Firazyr 49 neurology oncology 49 receptor agonist 49 neuroscience autoimmune 49 Golimumab 49 SNT MC# 49 Synavive 49 HIV integrase inhibitors 49 Namenda ® 49 EndoTAG TM 49 dermatologic diseases 49 multiple sclerosis lupus 49 deacetylase inhibitors 49 delta gamma agonist 49 idiopathic thrombocytopenic purpura ITP 49 Curaxin 49 pathophysiological mechanisms 49 TELINTRA 49 blood coagulation disorders 49 Trophos 49 Nexavar sorafenib 49 KRN# 49 Zalicus 49 chronic opioid 49 immune modulating 49 oncology infectious diseases 49 MPS VI 49 Oncaspar 49 Dyax phage display 49 BENLYSTA ® 49 mediated amyloidosis ATTR hypercholesterolemia 49 catalytic antioxidant compounds 49 RhuDex 49 Anti Infectives 49 Celsion Corporation 49 Talabostat 49 #ME# 49 multiple sclerosis psoriasis 49 aripiprazole Abilify 49 Leber Hereditary Optic Neuropathy 49 oral anticancer 49 drug ISA# 49 vascular occlusive diseases 49 histone deacetylase HDAC inhibitors 49 post herpetic 49 Desmoteplase 49 including thyroiditis RA 49 COPD asthma 49 Frova ® 49 fluocinolone acetonide 49 synthetic siRNA 49 desvenlafaxine 49 immune modulators 49 multiple sclerosis MS 49 CCX# 49 atopic dermatitis neonatal 49 VentiRx 49 Dicer Substrate Technology 49 Corporation Nasdaq CRGN 49 MultiStem 49 Gleevec imatinib mesylate 49 novel synthetic peptide 49 Aeolus Pharmaceuticals 49 CK # novel 49 methylnaltrexone 49 systemic lupus erythematosus psoriasis 49 haematological cancers 49 urological diseases 49 Adrenomyeloneuropathy AMN HIV 49 TLR8 49 resolvins 49 Phenomix Corporation 49 NASDAQ OPXA 49 sd rxRNA 49 novel peptides 49 EP #R 49 opioid tolerant patients 49 Fibrillex TM 49 rufinamide 49 RHEI 49 otelixizumab 49 Inc. AMEX AEN 49 Troxatyl 49 cachexia anti infectives 49 coupled receptors GPCRs 49 Hsp# inhibitors 49 Alnylam #x# 49 rusalatide acetate 49 nalbuphine ER 49 OHR/AVR# 49 inflammation autoimmune diseases 49 rheumatoid arthritis osteoarthritis ankylosing 49 Vaprisol 49 OTCQB CTIX 49 Therapeutic antibodies 49 antibiotic resistant bacterial infections 49 Galenea 49 engineered proteases 49 autonomic neuropathy 49 RECOTHROM R 49 neurostimulation 49 retinal dystrophies 49 noncancer pain 49 pulmonary arterial hypertension 49 Anticalin R 49 PHX# 49 LEVADEX TM 49 ropinirole Requip 49 Azedra 49 small molecule glucokinase 49 primary dysmenorrhea 49 PEGylation technology 49 Atypical antipsychotics 49 intracellular signaling pathways 49 humanized monoclonal 49 autologous cell 49 AAT Deficiency 49 Fc fusion protein 49 diseases 49 VisEn Medical 49 venous stasis ulcers 49 multiple myeloma MM 49 selective angiogenic kinase inhibitor 49 hypertension congestive heart